The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer

The Lipase/Amylase Ratio (LAR) in Peripheral Blood Might Represent a Novel Prognostic Marker in Patients with Surgically Resectable Pancreatic Cancer

Pancreatic enzymes might play a pivotal role in the pathophysiology and prognosis of pancreatic cancer. The aim of this study is to investigate the lipase/amylase ratio (LAR), representing a marker previously used in the differentiation of pancreatitis, as a potential prognostic marker in pancreatic...

Full description

Bibliographic Details
Main Authors: Michael Stotz, Dominik A. Barth, Jakob M. Riedl, Eva Asamer, Eva V. Klocker, Peter Kornprat, Georg C. Hutterer, Felix Prinz, Karoline Lackner, Herbert Stöger, Armin Gerger, Martin Pichler
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
amylase
lipase
pancreatic cancer
prognosis
surgical resection
Online Access:https://www.mdpi.com/2072-6694/12/7/1798

Internet

https://www.mdpi.com/2072-6694/12/7/1798

Similar Items